SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-005694
Filing Date
2022-04-14
Accepted
2022-04-14 16:01:33
Documents
12
Period of Report
2022-04-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K vor-20220411.htm   iXBRL 8-K 68106
  Complete submission text file 0000950170-22-005694.txt   190125

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vor-20220411_pre.xml EX-101.PRE 11466
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vor-20220411_lab.xml EX-101.LAB 13996
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vor-20220411.xsd EX-101.SCH 2487
6 EXTRACTED XBRL INSTANCE DOCUMENT vor-20220411_htm.xml XML 4887
Mailing Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39979 | Film No.: 22827194
SIC: 2836 Biological Products, (No Diagnostic Substances)